Symbols / NSYS
NSYS Chart
About
Nortech Systems Incorporated provides engineering design and manufacturing solutions for electromedical devices, electromechanical systems, assemblies, and components in the United States, Mexico, and China. It offers a range of value-added engineering, technical, manufacturing, and support services, including project management, designing, testing, prototyping, manufacturing, supply chain management, and post-market services. The company also manufacturing and engineering services that include complex electromedical and electromechanical product, such as medical devices, wire and cable assemblies, printed circuit board assemblies, complex higher-level assemblies, and other box builds for a range of industries. In addition, it offers engineering and repair services. The company serves original equipment manufacturers in the medical devices and imaging, aerospace and defense, and industrial markets through business development teams and independent manufacturers' representatives. Nortech Systems Incorporated was founded in 1990 and is headquartered in Maple Grove, Minnesota.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 25.13M |
| Enterprise Value | 45.21M | Income | -2.63M | Sales | 116.67M |
| Book/sh | 11.88 | Cash/sh | 0.46 | Dividend Yield | — |
| Payout | 0.00% | Employees | 701 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 0.22 | P/B | 0.76 | P/C | — |
| EV/EBITDA | 61.01 | EV/Sales | 0.39 | Quick Ratio | 1.05 |
| Current Ratio | 1.76 | Debt/Eq | 63.24 | LT Debt/Eq | — |
| EPS (ttm) | -0.95 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -2.90% | Earnings | — | ROA | -0.48% |
| ROE | -7.61% | ROIC | — | Gross Margin | 13.51% |
| Oper. Margin | 3.10% | Profit Margin | -2.25% | Shs Outstand | 2.79M |
| Shs Float | 938.65K | Short Float | 0.79% | Short Ratio | 1.90 |
| Short Interest | — | 52W High | 12.40 | 52W Low | 6.50 |
| Beta | -0.01 | Avg Volume | 5.70K | Volume | 2.90K |
| Target Price | — | Recom | None | Prev Close | $8.75 |
| Price | $9.02 | Change | 3.09% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- (NSYS) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily Fri, 20 Feb 2026 04
- Nortech Systems Inc (NSYS) Q3 2025 Earnings Call Highlights: Restructuring Boosts Efficiency ... - Yahoo Finance hu, 13 Nov 2025 08
- Nortech Systems Incorporated's (NASDAQ:NSYS) Price Is Right But Growth Is Lacking After Shares Rocket 29% - simplywall.st ue, 03 Feb 2026 08
- There's No Escaping Nortech Systems Incorporated's (NASDAQ:NSYS) Muted Revenues Despite A 29% Share Price Rise - 富途牛牛 ue, 03 Feb 2026 08
- Retail Trends: Is NSYS stock heavily shorted - Market Sentiment Report & Real-Time Market Trend Scan - baoquankhu1.vn hu, 19 Feb 2026 18
- Synopsys completes acquisition of Ansys and delisting from Nasdaq - Investing.com hu, 17 Jul 2025 07
- Here's Why Nortech Systems (NASDAQ:NSYS) Can Afford Some Debt - simplywall.st Mon, 19 Jan 2026 08
- A | Is Avery Dennison Corporation’s ROE strong enough - 2025 Geopolitical Influence & Technical Pattern Recognition Alerts - mfd.ru hu, 12 Feb 2026 13
- Earnings call transcript: Nortech Systems Q3 2025 sees stock dip amid net loss - Investing.com hu, 13 Nov 2025 08
- Synopsys to Acquire Ansys, Creating a Leader in Silicon to Systems Design Solutions - Synopsys ue, 16 Jan 2024 08
- Nortech Systems Incorporated Earns AS9100 Certification for Monterrey, Mexico Facility - Business Wire ue, 04 Nov 2025 08
- What is NSYS s 5 year growth outlook - Quarterly Profit Report & Weekly Setup with High ROI Potential - mfd.ru Mon, 09 Feb 2026 03
- Synopsys to acquire graphics software maker Ansys in $35 billion tech deal - CNBC ue, 16 Jan 2024 08
- Opioids, Bribery And Wall Street: The Inside Story Of A Disgraced Drugmaker - PBS hu, 18 Jun 2020 07
- Insys Therapeutics, opioid maker implicated in major kickback scheme, files for bankruptcy - statnews.com Mon, 10 Jun 2019 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 9284 | 81049 | — | Stock Award(Grant) at price 8.73 per share. | KUNIN DAVID B | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2025-05-19 00:00:00 | D |
| 1 | 6876 | 60027 | — | Stock Award(Grant) at price 8.73 per share. | KRUSE STACY A | Director | — | 2025-05-19 00:00:00 | D |
| 2 | 6876 | 60027 | — | Stock Award(Grant) at price 8.73 per share. | MCMANUS RYAN P | Director | — | 2025-05-19 00:00:00 | D |
| 3 | 6876 | 60027 | — | Stock Award(Grant) at price 8.73 per share. | FREDREGILL AMY S | Director | — | 2025-05-19 00:00:00 | D |
| 4 | 6876 | 60027 | — | Stock Award(Grant) at price 8.73 per share. | PERIS JOSE ANTONIO | Director | — | 2025-05-19 00:00:00 | D |
| 5 | 6876 | 60027 | — | Stock Award(Grant) at price 8.73 per share. | SEN DEBARATI | Director | — | 2025-05-19 00:00:00 | D |
| 6 | 1981 | 21910 | — | Stock Award(Grant) at price 11.06 per share. | KUNIN DAVID B | Director and Beneficial Owner of more than 10% of a Class of Security | — | 2024-05-20 00:00:00 | D |
| 7 | 1981 | 21910 | — | Stock Award(Grant) at price 11.06 per share. | KRUSE STACY A | Director | — | 2024-05-20 00:00:00 | D |
| 8 | 1981 | 21910 | — | Stock Award(Grant) at price 11.06 per share. | MCMANUS RYAN P | Director | — | 2024-05-20 00:00:00 | D |
| 9 | 1981 | 21910 | — | Stock Award(Grant) at price 11.06 per share. | SACHS DANNY M.D. | Director | — | 2024-05-20 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -119.91K | 0.00 | 3.15K | 651.00K |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.12 |
| NormalizedEBITDA | 2.11M | 8.00M | 5.79M | 4.97M |
| TotalUnusualItems | -571.00K | 0.00 | 15.00K | 5.42M |
| TotalUnusualItemsExcludingGoodwill | -571.00K | 0.00 | 15.00K | 5.42M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -1.29M | 6.87M | 2.01M | 7.15M |
| ReconciledDepreciation | 1.74M | 2.05M | 1.92M | 1.95M |
| ReconciledCostOfRevenue | 111.41M | 116.23M | 113.64M | 99.30M |
| EBITDA | 1.54M | 8.00M | 5.81M | 10.39M |
| EBIT | -195.00K | 5.95M | 3.89M | 8.44M |
| NetInterestIncome | -744.00K | -487.00K | -411.00K | -430.00K |
| InterestExpense | 744.00K | 487.00K | 411.00K | 430.00K |
| NormalizedIncome | -843.91K | 6.87M | 2.00M | 2.38M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -1.29M | 6.87M | 2.01M | 7.15M |
| TotalExpenses | 127.76M | 133.38M | 130.25M | 112.15M |
| TotalOperatingIncomeAsReported | -195.00K | 5.95M | 3.89M | 2.27M |
| DilutedAverageShares | 2.76M | 2.89M | 2.89M | 2.82M |
| BasicAverageShares | 2.76M | 2.72M | 2.69M | 2.66M |
| DilutedEPS | -0.47 | 2.38 | 0.70 | 2.54 |
| BasicEPS | -0.47 | 2.53 | 0.75 | 2.68 |
| DilutedNIAvailtoComStockholders | -1.29M | 6.87M | 2.01M | 7.15M |
| NetIncomeCommonStockholders | -1.29M | 6.87M | 2.01M | 7.15M |
| NetIncome | -1.29M | 6.87M | 2.01M | 7.15M |
| NetIncomeIncludingNoncontrollingInterests | -1.29M | 6.87M | 2.01M | 7.15M |
| NetIncomeContinuousOperations | -1.29M | 6.87M | 2.01M | 7.15M |
| TaxProvision | 356.00K | -1.41M | 1.47M | 859.00K |
| PretaxIncome | -939.00K | 5.47M | 3.48M | 8.01M |
| OtherIncomeExpense | -571.00K | 15.00K | 5.42M | |
| SpecialIncomeCharges | -571.00K | 0.00 | 15.00K | 5.42M |
| GainOnSaleOfPPE | 0.00 | 15.00K | -419.00K | |
| OtherSpecialCharges | -6.17M | |||
| ImpairmentOfCapitalAssets | 560.00K | |||
| RestructuringAndMergernAcquisition | 571.00K | 0.00 | 0.00 | 327.00K |
| NetNonOperatingInterestIncomeExpense | -744.00K | -487.00K | -411.00K | -430.00K |
| InterestExpenseNonOperating | 744.00K | 487.00K | 411.00K | 430.00K |
| OperatingIncome | 376.00K | 5.95M | 3.87M | 3.02M |
| OperatingExpense | 16.35M | 17.15M | 16.61M | 12.85M |
| ResearchAndDevelopment | 1.19M | 1.20M | 1.46M | 483.00K |
| SellingGeneralAndAdministration | 15.15M | 15.95M | 15.14M | 12.36M |
| SellingAndMarketingExpense | 3.45M | 3.60M | 3.72M | 2.36M |
| GeneralAndAdministrativeExpense | 11.71M | 12.35M | 11.43M | 10.00M |
| OtherGandA | 11.71M | 12.35M | 11.43M | 10.00M |
| GrossProfit | 16.72M | 23.10M | 20.48M | 15.86M |
| CostOfRevenue | 111.41M | 116.23M | 113.64M | 99.30M |
| TotalRevenue | 128.13M | 139.33M | 134.12M | 115.17M |
| OperatingRevenue | 128.13M | 139.33M | 134.12M | 115.17M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| PreferredSharesNumber | 250.00K | 250.00K | 250.00K | 250.00K |
| OrdinarySharesNumber | 2.76M | 2.69M | 2.69M | 2.67M |
| ShareIssued | 2.76M | 2.69M | 2.69M | 2.67M |
| NetDebt | 7.72M | 4.86M | 5.83M | 8.32M |
| TotalDebt | 18.04M | 14.18M | 16.51M | 20.21M |
| TangibleBookValue | 33.58M | 34.83M | 27.41M | 25.36M |
| InvestedCapital | 42.39M | 40.91M | 34.68M | 34.82M |
| WorkingCapital | 33.89M | 32.21M | 28.46M | 29.47M |
| NetTangibleAssets | 33.83M | 35.08M | 27.66M | 25.61M |
| CapitalLeaseObligations | 9.40M | 8.36M | 9.66M | 11.26M |
| CommonStockEquity | 33.76M | 35.09M | 27.83M | 25.86M |
| PreferredStockEquity | 250.00K | 250.00K | 250.00K | 250.00K |
| TotalCapitalization | 42.64M | 41.16M | 34.93M | 35.07M |
| TotalEquityGrossMinorityInterest | 34.01M | 35.34M | 28.08M | 26.11M |
| StockholdersEquity | 34.01M | 35.34M | 28.08M | 26.11M |
| GainsLossesNotAffectingRetainedEarnings | -977.00K | -532.00K | -370.00K | 56.00K |
| OtherEquityAdjustments | -977.00K | -532.00K | -370.00K | 56.00K |
| RetainedEarnings | 17.38M | 18.67M | 11.83M | 9.82M |
| AdditionalPaidInCapital | 17.33M | 16.93M | 16.35M | 15.96M |
| CapitalStock | 278.00K | 277.00K | 277.00K | 277.00K |
| CommonStock | 28.00K | 27.00K | 27.00K | 27.00K |
| PreferredStock | 250.00K | 250.00K | 250.00K | 250.00K |
| TotalLiabilitiesNetMinorityInterest | 38.43M | 39.78M | 41.46M | 40.98M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 17.00M | 13.20M | 15.06M | 18.67M |
| OtherNonCurrentLiabilities | 284.00K | 414.00K | 95.00K | 104.00K |
| LongTermDebtAndCapitalLeaseObligation | 16.72M | 12.79M | 14.97M | 18.57M |
| LongTermCapitalLeaseObligation | 8.08M | 6.97M | 8.11M | 9.61M |
| LongTermDebt | 8.63M | 5.82M | 6.85M | 8.96M |
| CurrentLiabilities | 21.43M | 26.58M | 26.40M | 22.31M |
| CurrentDeferredLiabilities | 5.14M | 4.07M | 3.52M | |
| CurrentDeferredRevenue | 5.14M | 4.07M | 3.52M | |
| CurrentDebtAndCapitalLeaseObligation | 1.32M | 1.39M | 1.54M | 1.64M |
| CurrentCapitalLeaseObligation | 1.32M | 1.39M | 1.54M | 1.64M |
| PayablesAndAccruedExpenses | 14.97M | 21.12M | 21.34M | 20.66M |
| CurrentAccruedExpenses | 3.39M | 5.20M | 6.55M | 7.95M |
| Payables | 11.58M | 15.92M | 14.79M | 12.71M |
| AccountsPayable | 11.58M | 15.92M | 14.79M | 12.71M |
| TotalAssets | 72.44M | 75.13M | 69.54M | 67.09M |
| TotalNonCurrentAssets | 17.12M | 16.33M | 14.68M | 15.32M |
| NonCurrentDeferredAssets | 2.58M | 2.64M | 0.00 | |
| NonCurrentDeferredTaxesAssets | 2.58M | 2.64M | 0.00 | |
| GoodwillAndOtherIntangibleAssets | 174.00K | 263.00K | 422.00K | 501.00K |
| OtherIntangibleAssets | 174.00K | 263.00K | 422.00K | 501.00K |
| NetPPE | 14.37M | 13.43M | 14.26M | 14.82M |
| AccumulatedDepreciation | -27.27M | -26.94M | -24.98M | -24.22M |
| GrossPPE | 41.64M | 40.37M | 39.24M | 39.04M |
| OtherProperties | 28.95M | 26.79M | 26.98M | 18.89M |
| MachineryFurnitureEquipment | 6.52M | 7.38M | 6.82M | 6.93M |
| BuildingsAndImprovements | 6.03M | 6.04M | 5.29M | 13.07M |
| LandAndImprovements | 148.00K | 148.00K | 148.00K | 148.00K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 55.31M | 58.79M | 54.86M | 51.77M |
| OtherCurrentAssets | 4.09M | 1.70M | 1.33M | 1.66M |
| RestrictedCash | 0.00 | 715.00K | 1.45M | 1.58M |
| PrepaidAssets | 1.33M | 1.66M | ||
| Inventory | 21.64M | 21.66M | 22.44M | 19.43M |
| InventoriesAdjustmentsAllowances | -1.45M | -1.17M | -1.14M | -1.30M |
| FinishedGoods | 1.07M | 934.00K | 671.00K | 562.00K |
| WorkInProcess | 892.00K | 1.03M | 1.24M | 1.68M |
| RawMaterials | 21.12M | 20.86M | 21.67M | 18.49M |
| Receivables | 28.67M | 33.76M | 28.61M | 28.45M |
| OtherReceivables | 13.79M | 14.48M | 12.63M | 8.70M |
| AccountsReceivable | 14.88M | 19.28M | 15.97M | 19.76M |
| AllowanceForDoubtfulAccountsReceivable | -196.00K | -358.00K | -328.00K | -328.00K |
| GrossAccountsReceivable | 15.07M | 19.64M | 16.30M | 20.09M |
| CashCashEquivalentsAndShortTermInvestments | 916.00K | 960.00K | 1.03M | 643.00K |
| CashAndCashEquivalents | 916.00K | 960.00K | 1.03M | 643.00K |
| CashFinancial | 916.00K | 960.00K | 1.03M | 643.00K |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -3.52M | 485.00K | 2.96M | -5.90M |
| RepurchaseOfCapitalStock | -100.00K | 0.00 | ||
| RepaymentOfDebt | -127.31M | -125.99M | -122.07M | -105.65M |
| IssuanceOfDebt | 130.14M | 124.55M | 119.35M | 109.54M |
| CapitalExpenditure | -1.27M | -1.28M | -2.44M | -1.36M |
| InterestPaidSupplementalData | 764.00K | 503.00K | 476.00K | 316.00K |
| IncomeTaxPaidSupplementalData | 473.00K | 1.75M | 237.00K | |
| EndCashPosition | 916.00K | 1.68M | 2.48M | 2.23M |
| BeginningCashPosition | 1.68M | 2.48M | 2.23M | 3.56M |
| EffectOfExchangeRateChanges | -11.00K | -10.00K | -53.00K | 0.00 |
| ChangesInCash | -748.00K | -796.00K | 309.00K | -1.34M |
| FinancingCashFlow | 2.77M | -1.28M | -2.67M | 3.93M |
| CashFlowFromContinuingFinancingActivities | 2.77M | -1.28M | -2.67M | 3.93M |
| ProceedsFromStockOptionExercised | 38.00K | 159.00K | 51.00K | 35.00K |
| NetCommonStockIssuance | -100.00K | 0.00 | ||
| CommonStockPayments | -100.00K | 0.00 | ||
| NetIssuancePaymentsOfDebt | 2.83M | -1.44M | -2.72M | 3.90M |
| NetShortTermDebtIssuance | 5.69M | |||
| NetLongTermDebtIssuance | 2.83M | -1.44M | -2.72M | 3.90M |
| LongTermDebtPayments | -127.31M | -125.99M | -122.07M | -105.65M |
| LongTermDebtIssuance | 130.14M | 124.55M | 119.35M | 109.54M |
| InvestingCashFlow | -1.26M | -1.28M | -2.43M | -730.00K |
| CashFlowFromContinuingInvestingActivities | -1.26M | -1.28M | -2.43M | -730.00K |
| NetIntangiblesPurchaseAndSale | 0.00 | -71.00K | -64.00K | |
| PurchaseOfIntangibles | 0.00 | -71.00K | -64.00K | |
| NetPPEPurchaseAndSale | -1.26M | -1.28M | -2.35M | -666.00K |
| SaleOfPPE | 7.00K | 0.00 | 15.00K | 626.00K |
| PurchaseOfPPE | -1.27M | -1.28M | -2.37M | -1.29M |
| OperatingCashFlow | -2.25M | 1.77M | 5.40M | -4.54M |
| CashFlowFromContinuingOperatingActivities | -2.25M | 1.77M | 5.40M | -4.54M |
| ChangeInWorkingCapital | -3.24M | -5.27M | 1.37M | -7.27M |
| ChangeInOtherWorkingCapital | 1.07M | 553.00K | 550.00K | 634.00K |
| ChangeInPayablesAndAccruedExpense | -6.62M | -260.00K | 3.30M | 3.75M |
| ChangeInAccruedExpense | -2.66M | -743.00K | 1.08M | 2.28M |
| ChangeInPayable | -3.96M | 483.00K | 2.22M | 1.47M |
| ChangeInAccountPayable | -3.96M | 483.00K | 2.22M | 1.47M |
| ChangeInPrepaidAssets | -2.05M | -147.00K | 317.00K | -171.00K |
| ChangeInInventory | -400.00K | 716.00K | -2.98M | -4.61M |
| ChangeInReceivables | 4.76M | -6.13M | 188.00K | -6.87M |
| ChangesInAccountReceivables | 4.41M | -3.43M | -1.75M | 1.13M |
| OtherNonCashItems | 143.00K | |||
| StockBasedCompensation | 461.00K | 423.00K | 334.00K | 111.00K |
| ProvisionandWriteOffofAssets | 118.00K | 50.00K | -143.00K | -875.00K |
| AssetImpairmentCharge | 0.00 | |||
| DeferredTax | -12.00K | -2.36M | 0.00 | |
| DeferredIncomeTax | -12.00K | -2.36M | 0.00 | |
| DepreciationAmortizationDepletion | 1.74M | 2.05M | 1.92M | 1.95M |
| DepreciationAndAmortization | 1.74M | 2.05M | 1.92M | 1.95M |
| AmortizationCashFlow | 89.00K | 159.00K | 150.00K | 176.00K |
| AmortizationOfIntangibles | 89.00K | 159.00K | 150.00K | 176.00K |
| Depreciation | 1.65M | 1.89M | 1.77M | 1.77M |
| OperatingGainsLosses | -23.00K | 2.00K | -87.00K | -5.75M |
| NetForeignCurrencyExchangeGainLoss | 2.00K | -72.00K | 0.00 | |
| GainLossOnSaleOfPPE | -23.00K | 0.00 | -15.00K | 419.00K |
| NetIncomeFromContinuingOperations | -1.29M | 6.87M | 2.01M | 7.15M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for NSYS
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|